Notably, the population of Foxp3 + Tregs showed no significant alteration, while a higher ratio of CD8 + T cells to Foxp3 + Tregs in the pre-treatment biopsies was associated with tumor regression. The gene discussed is CD8A; the disease is neoplasm.